Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or .beta.-sheet rich pathological precursor thereof
CA 2389041 A1 · Owner: Axonyx, Inc. · Inventors: Soto-Jara, Claudio
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is an inhibitory peptide capable of inhibiting .beta. pleated sheet formation in amyloid .beta.-peptide. The inhibitory peptide is a .beta.sheet breaker peptide analog designed by chemical modification of .beta. sheet breaker peptide capable of inhibiting .beta. pleated sheet formation in amyloid .beta.-peptide. The present invention also includes an inhibitory peptide capable of inhibiting conformational changes in prion PrP protein associated with amyloidosis. The inhibitory peptide being a .beta.sheet breaker peptide analog designed by chemical modification of a .beta.sheet breaker peptide capable of inhibiting the conformational changes in prior PrP …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed November 4, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 4, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 4, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.